Narasaem Lee, Subin Kim, Na Young Lee, Heeji Jo, Pyeonghwa Jeong, Haushabhau S Pagire, Suvarna H Pagire, Jin Hee Ahn, Mi Sun Jin, Chul-Seung Park
{"title":"BKCa 通道激活剂 CTIBD 的激活机制和新的结合位点。","authors":"Narasaem Lee, Subin Kim, Na Young Lee, Heeji Jo, Pyeonghwa Jeong, Haushabhau S Pagire, Suvarna H Pagire, Jin Hee Ahn, Mi Sun Jin, Chul-Seung Park","doi":"10.26508/lsa.202402621","DOIUrl":null,"url":null,"abstract":"<p><p>The large-conductance calcium-activated potassium (BK<sub>Ca</sub>) channel, which is crucial for urinary bladder smooth muscle relaxation, is a potential target for overactive bladder treatment. Our prior work unveiled CTIBD as a promising BK<sub>Ca</sub> channel activator, altering <i>V</i> <sub><i>1/2</i></sub> and <i>G</i> <sub><i>max</i></sub> This study investigates CTIBD's activation mechanism, revealing its independence from the Ca<sup>2+</sup> and membrane voltage sensing of the BK<sub>Ca</sub> channel. Cryo-electron microscopy disclosed that two CTIBD molecules bind to hydrophobic regions on the extracellular side of the lipid bilayer. Key residues (W22, W203, and F266) are important for CTIBD binding, and their replacement with alanine reduces CTIBD-mediated channel activation. The triple-mutant (W22A/W203A/F266A) channel showed the smallest <i>V</i> <sub><i>1/2</i></sub> shift with a minimal impact on activation and deactivation kinetics by CTIBD. At the single-channel level, CTIBD treatment was much less effective at increasing <i>P</i> <sub><i>o</i></sub> in the triple mutant, mainly because of a drastically increased dissociation rate compared with the WT. These findings highlight CTIBD's mechanism, offering crucial insights for developing small-molecule treatments for BK<sub>Ca</sub>-related pathophysiological conditions.</p>","PeriodicalId":18081,"journal":{"name":"Life Science Alliance","volume":"7 10","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11294680/pdf/","citationCount":"0","resultStr":"{\"title\":\"Activation mechanism and novel binding sites of the BK<sub>Ca</sub> channel activator CTIBD.\",\"authors\":\"Narasaem Lee, Subin Kim, Na Young Lee, Heeji Jo, Pyeonghwa Jeong, Haushabhau S Pagire, Suvarna H Pagire, Jin Hee Ahn, Mi Sun Jin, Chul-Seung Park\",\"doi\":\"10.26508/lsa.202402621\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The large-conductance calcium-activated potassium (BK<sub>Ca</sub>) channel, which is crucial for urinary bladder smooth muscle relaxation, is a potential target for overactive bladder treatment. Our prior work unveiled CTIBD as a promising BK<sub>Ca</sub> channel activator, altering <i>V</i> <sub><i>1/2</i></sub> and <i>G</i> <sub><i>max</i></sub> This study investigates CTIBD's activation mechanism, revealing its independence from the Ca<sup>2+</sup> and membrane voltage sensing of the BK<sub>Ca</sub> channel. Cryo-electron microscopy disclosed that two CTIBD molecules bind to hydrophobic regions on the extracellular side of the lipid bilayer. Key residues (W22, W203, and F266) are important for CTIBD binding, and their replacement with alanine reduces CTIBD-mediated channel activation. The triple-mutant (W22A/W203A/F266A) channel showed the smallest <i>V</i> <sub><i>1/2</i></sub> shift with a minimal impact on activation and deactivation kinetics by CTIBD. At the single-channel level, CTIBD treatment was much less effective at increasing <i>P</i> <sub><i>o</i></sub> in the triple mutant, mainly because of a drastically increased dissociation rate compared with the WT. These findings highlight CTIBD's mechanism, offering crucial insights for developing small-molecule treatments for BK<sub>Ca</sub>-related pathophysiological conditions.</p>\",\"PeriodicalId\":18081,\"journal\":{\"name\":\"Life Science Alliance\",\"volume\":\"7 10\",\"pages\":\"\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11294680/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Life Science Alliance\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.26508/lsa.202402621\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/1 0:00:00\",\"PubModel\":\"Print\",\"JCR\":\"Q1\",\"JCRName\":\"BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Life Science Alliance","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.26508/lsa.202402621","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/1 0:00:00","PubModel":"Print","JCR":"Q1","JCRName":"BIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
大电导钙激活钾(BKCa)通道对膀胱平滑肌松弛至关重要,是治疗膀胱过度活动症的潜在靶点。我们之前的研究揭示了 CTIBD 是一种很有前景的 BKCa 通道激活剂,它能改变 V 1/2 和 G max。这项研究调查了 CTIBD 的激活机制,揭示了它与 BKCa 通道的 Ca2+ 和膜电压感应无关。冷冻电镜显示,两个 CTIBD 分子与脂质双分子层细胞外侧的疏水区域结合。关键残基(W22、W203 和 F266)对 CTIBD 的结合非常重要,用丙氨酸取代这些残基会降低 CTIBD 介导的通道激活。三重突变体(W22A/W203A/F266A)通道的 V 1/2 漂移最小,对 CTIBD 激活和失活动力学的影响也最小。在单通道水平上,CTIBD 处理对增加三重突变体 P o 的效果要差得多,这主要是因为与 WT 相比,三重突变体的解离率急剧增加。这些发现强调了 CTIBD 的作用机制,为开发治疗 BKCa 相关病理生理状况的小分子疗法提供了重要启示。
Activation mechanism and novel binding sites of the BKCa channel activator CTIBD.
The large-conductance calcium-activated potassium (BKCa) channel, which is crucial for urinary bladder smooth muscle relaxation, is a potential target for overactive bladder treatment. Our prior work unveiled CTIBD as a promising BKCa channel activator, altering V1/2 and Gmax This study investigates CTIBD's activation mechanism, revealing its independence from the Ca2+ and membrane voltage sensing of the BKCa channel. Cryo-electron microscopy disclosed that two CTIBD molecules bind to hydrophobic regions on the extracellular side of the lipid bilayer. Key residues (W22, W203, and F266) are important for CTIBD binding, and their replacement with alanine reduces CTIBD-mediated channel activation. The triple-mutant (W22A/W203A/F266A) channel showed the smallest V1/2 shift with a minimal impact on activation and deactivation kinetics by CTIBD. At the single-channel level, CTIBD treatment was much less effective at increasing Po in the triple mutant, mainly because of a drastically increased dissociation rate compared with the WT. These findings highlight CTIBD's mechanism, offering crucial insights for developing small-molecule treatments for BKCa-related pathophysiological conditions.
期刊介绍:
Life Science Alliance is a global, open-access, editorially independent, and peer-reviewed journal launched by an alliance of EMBO Press, Rockefeller University Press, and Cold Spring Harbor Laboratory Press. Life Science Alliance is committed to rapid, fair, and transparent publication of valuable research from across all areas in the life sciences.